Drug firm Abbott India Ltd on Wednesday (August 7) reported a 13% year-on-year (YoY) increase in net profit at ₹328 crore for the first quarter that ended June 30, 2024.

In the corresponding quarter, Abbott India posted a net profit of ₹290 crore, the company said in a regulatory filing. Abbott’s revenue from operations grew 5.3% to ₹1,557.6 crore against ₹1,479 crore in the corresponding period of the preceding fiscal.

Also Read: Dr Lal PathLabs beats the Street, declares dividend of ₹6 as Q1 net profit surges 30%

At the operating level, EBITDA rises 10.2% to ₹391.1 crore in the first quarter of this fiscal over ₹355 crore in the year-ago period.

The EBITDA margin stood at 25.1% in the reporting quarter against 24% in the first quarter of FY24. EBITDA is earnings before interest, tax, depreciation, and amortisation.

The results came after the close of the market hours. Shares of Abbott India Ltd ended at ₹27,929.55, up by ₹128.10, or 0.46%, on the BSE.

Also Read: Lupin Q1 Results | Net profit spikes 77% to ₹801 crore, beats estimates